| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 10/01/2009 | US20090246202 Human Endokine Alpha and Methods of Use |
| 10/01/2009 | US20090246201 Substances |
| 10/01/2009 | US20090246193 Inactivating organisms using carbon dioxide at or near its supercritical pressure and temperature conditions |
| 10/01/2009 | US20090246147 Delivery Of Antipsychotics Through An Inhalation Route |
| 10/01/2009 | US20090246130 Methods and Compositions for F-18 Labeling of Proteins, Peptides and Other Molecules |
| 10/01/2009 | CA2719719A1 Probiotics for use in expecting female mammals for enhancing the immunity of their offsprings |
| 10/01/2009 | CA2719290A1 Use of benzophenone derivative or salt thereof and tnf.alpha. inhibitor in combination and pharmaceutical composition containing the derivative or salt thereof and the inhibitor |
| 10/01/2009 | CA2718987A1 Method for crystallization of 2-amino-2-[2-[4-(3- benzyloxyphenylthio)-2-chlorophenyl]ethyl]-1,3-propanediol hydrochloride |
| 10/01/2009 | CA2712535A1 An anti-cancer cytotoxic monoclonal antibody |
| 09/30/2009 | EP2105502A1 Compositions and methods for the therapy and diagnosis of lung cancer |
| 09/30/2009 | EP2105448A2 High-yield method for the production of human antibodies blocking the biological activity of a human cytokine |
| 09/30/2009 | EP2105136A2 Pharmaceutical compositions for treating cancer |
| 09/30/2009 | EP2105135A2 Pharmaceutical compositions for treating cancer |
| 09/30/2009 | EP2105134A1 Stable amorphous fexofenadine hydrochloride |
| 09/30/2009 | EP2104738A2 Oligoribonucleotides and uses thereof |
| 09/30/2009 | EP2104732A1 Cancerous disease modifying antibodies |
| 09/30/2009 | EP2104534A1 New combination for use in the treatment of inflammatory disorders |
| 09/30/2009 | EP2104533A2 Use of substances reducing cellular glutathione content for producing a medicament for treating t-cell mediated autoimmune diseases |
| 09/30/2009 | EP2104504A2 Preventing or reducing oxidative stress or oxidative cell injury by the administration of a water-insoluble cellulose derivative |
| 09/30/2009 | EP1555028B1 Antiallergic agent, utilization thereof for reducing allergy and method of reducing allergy |
| 09/30/2009 | EP1453525B1 Selective targeting of apoptotic cells |
| 09/30/2009 | EP1451322B1 Il-21 antagonists |
| 09/30/2009 | EP1435944B1 4(4-alkoxy-3-hydroxyphenyl)-2-pyrrolidone derivatives as pde-4 inhibitors for the treatment of neurological syndromes |
| 09/30/2009 | EP1296701B1 Use of grifola frondosa fungus extracts |
| 09/30/2009 | EP1242122B1 Delivery of proteins across polar epithelial cell layers |
| 09/30/2009 | EP1185655B1 Equine granulocyte-macrophage colony-stimulating factor (gm-csf) |
| 09/30/2009 | EP0623168B1 T cell epitopes of the major allergens from dermatophagoides (house dust mite) |
| 09/30/2009 | CN101544693A Recombined extrasin alpha 1 two-strand body protein and preparation method thereof |
| 09/30/2009 | CN101544686A Application of glycopeptide mixture in preparing adjuvant therapy medicaments of tumor and health food |
| 09/30/2009 | CN101544654A Dimer (5-methylol-furfural), synthetic method thereof and medical application thereof |
| 09/30/2009 | CN101543597A Medicine composition for nourishing spleen and kidney and building up healthful vital energy and preparation method thereof |
| 09/30/2009 | CN101543594A Mulberry-chrysanthemum oral liquid |
| 09/30/2009 | CN101543546A Antioxidative substance and composition and use thereof |
| 09/30/2009 | CN101543507A Immunostimulatory nucleic acids |
| 09/30/2009 | CN101543500A Dhea composition and method |
| 09/30/2009 | CN101543484A Transdermal drug delivery preparation containing chitin or derivate thereof and preparation method thereof |
| 09/30/2009 | CN100545174C Compositions and methods for wt1 specific immunotherapy |
| 09/30/2009 | CN100544726C DHEA composition and method |
| 09/30/2009 | CN100544715C Composition of free-B-ring flavonoids and flavans as a therapeutic agent |
| 09/29/2009 | US7596455 Crystallization of IGF-1 |
| 09/29/2009 | US7595399 Tyrosine derivatives |
| 09/29/2009 | US7595341 Analogues of lipid mediators derived from ω-3 PUFAs and methods of use |
| 09/29/2009 | US7595301 Staple type oligonucleotide and drug comprising the same |
| 09/29/2009 | US7595064 Method of preparation and composition of a water soluble extract of the bioactive component of the plant species Uncaria for enhancing immune, anti-inflammatory, anti-tumor and DNA repair processes of warm blooded animals |
| 09/29/2009 | US7595052 Composition and method for the prevention and/or the treatment of allergy |
| 09/29/2009 | US7595048 Method for treatment of cancer by inhibiting the immunosuppressive signal induced by PD-1 |
| 09/29/2009 | CA2484460C Polymorph of 4-[2-[4-[1-(2-ethoxyethyl)-1h-benzimidazole-2-yl]-1-piperidinyl]ethyl]-.alpha..alpha. dimethyl-benzeneacetic acid |
| 09/29/2009 | CA2469350C 3-{4-methyl-3[methyl-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-amino]-piperidin-1-yl}-3-oxo-propionitrile mono citrate salt |
| 09/29/2009 | CA2457944C Polycyclic guanine phosphodiesterase v inhibitors |
| 09/29/2009 | CA2446741C Ophthalmic drug delivery device |
| 09/29/2009 | CA2434009C Conjugates of immune cell specific macrolide compounds with anti-inflammatory compounds for improved cellular targeting of anti-inflammatory therapy |
| 09/29/2009 | CA2391085C Bis-basic compounds as tryptase inhibitors, processes for preparing them and their use as phamaceutical compositions |
| 09/29/2009 | CA2379560C Purine derivatives inhibitors of tyrosine protein kinase syk |
| 09/29/2009 | CA2375670C 5-phenyl-pyrimidine derivatives |
| 09/29/2009 | CA2334730C Novel cyclosporins |
| 09/29/2009 | CA2293489C Inhibitors of dna immunostimulatory sequence activity |
| 09/29/2009 | CA2274758C Stable glassy state powder formulations |
| 09/29/2009 | CA2217178C Vaccines containing a saponin and a sterol |
| 09/29/2009 | CA2194660C Growth differentiation factor-11 |
| 09/29/2009 | CA2100329C Methods for treating tumor necrosis factor mediated diseases |
| 09/28/2009 | CA2627903A1 Amphoteric microgels for the delivery of compounds to cells |
| 09/24/2009 | WO2009117736A2 Avian virus vaccines and uses thereof |
| 09/24/2009 | WO2009117640A2 Antibodies against interleukin-10 like cytokines and uses therefor |
| 09/24/2009 | WO2009117616A2 Carbon nanotube compositions and methods of use thereof |
| 09/24/2009 | WO2009117365A2 Vaccine compositons for inducing immune responses against components of drusen |
| 09/24/2009 | WO2009117085A1 Combinations and methods for subcutaneous administration of immune globulin and hyaluronidase |
| 09/24/2009 | WO2009116524A1 Modified protein |
| 09/24/2009 | WO2009115807A1 Inhibitors of the aryl hydrocarbon receptor for modulating the immune response |
| 09/24/2009 | WO2009115534A1 Process for the preparation of 2-amino-2- [2- (4-c3-c21-alkyl-phenyl)ethyl] propane-1, 3-diols |
| 09/24/2009 | WO2009115517A2 Organic compounds |
| 09/24/2009 | WO2009115496A1 Furo [3, 2-d] pyrimidine derivatives as h4 receptor antagonists |
| 09/24/2009 | WO2009115257A1 Substituted sulfonamide derivatives |
| 09/24/2009 | WO2009115023A1 A anthocyanins phospholipid complex and the preparative method thereof |
| 09/24/2009 | WO2009087285A4 5,6-diaryl pyridines substituted in the 2- and 3-position, preparation thereof and therapeutic use thereof |
| 09/24/2009 | WO2009068682A3 Phenyl-oxetanyl-derivatives |
| 09/24/2009 | WO2009061807A3 Activin receptor-like kinase-i antagonist compositions and methods of use |
| 09/24/2009 | WO2009044273A3 Use of recombinant lag-3 or the derivatives thereof for eliciting monocyte immune response |
| 09/24/2009 | WO2009040068A3 Use of a peptide as a therapeutic agent |
| 09/24/2009 | WO2009040067A3 Use of a peptide as a therapeutic agent |
| 09/24/2009 | WO2009040049A3 Use of acetyl- (ala10, 11)-rantes (1-14) and/or calcitonin as anti-angiogenic agents |
| 09/24/2009 | WO2009033681A3 Cyclo-argd as a therapeutic agent |
| 09/24/2009 | WO2009033680A3 Galanin-like peptide alone or in combination with cyclo-argd as a therapeutic agent |
| 09/24/2009 | WO2009032668A3 2 -biphenylamino-4 -aminopyrimidine derivatives as kinase inhibitors |
| 09/24/2009 | WO2009027077A3 5-arylalkylidene-2-arylalkyl-thiazol-4-one derivatives as inhibitors of 5-lipoxygenase and uses thereof |
| 09/24/2009 | WO2008030119A9 Acyclic amine inhibitors of nucleoside phosphorylases and hydrolases |
| 09/24/2009 | US20090239916 Novel drug discovery target and medicine acting on the same |
| 09/24/2009 | US20090239885 Inhibitors of nucleoside phoshorylases and nucleosidases |
| 09/24/2009 | US20090239883 Treatment of Pulmonary Hypertension |
| 09/24/2009 | US20090239847 Organic compounds |
| 09/24/2009 | US20090239842 Solutions containing epinastin |
| 09/24/2009 | US20090239839 Receptor antagonist |
| 09/24/2009 | US20090239813 Analogs of Alpha Galactosyceramide and Uses thereof |
| 09/24/2009 | US20090239805 Human 3 relaxin |
| 09/24/2009 | US20090239794 Hcv f protein and uses thereof |
| 09/24/2009 | US20090239265 Virus like particles |
| 09/24/2009 | US20090239240 Mutant Forms of Fas Ligand and Uses Thereof |
| 09/24/2009 | US20090238864 Dna vaccines encoding heat shock proteins |
| 09/24/2009 | US20090238843 Recombinant mva capable of expressing structural hcv antigens |
| 09/24/2009 | US20090238829 Stabilized single domain antibodies |
| 09/24/2009 | US20090238818 Induction of Antigen Specific Immunnologic Tolerance |